NF1 and central nervous system cancer: Since most of the alterations generate truncation mutants, it is conceivable that mutations observed in glioma patients will most likely abolish the interaction between the neurofibromin domains and their substrates and destabilise the actin filament organisation, thus affecting cell invasion.